TDCX Inc. to Report Third Quarter 2023 Results
SINGAPORE--(BUSINESS WIRE)--TDCX Inc. (“TDCX†or the “Companyâ€) (NYSE: TDCX), an award-winning digital customer experience solutions…
2 years ago
Wire Stories
BigBear.ai Announces Definitive Merger Agreement to Acquire Pangiam as well as First Quarter of Positive Net Income, Positive Adjusted EBITDA & Positive Cash Flows from Operations in Third Quarter 2023 Financial Results
Announced a definitive merger agreement to acquire Pangiam in an all-stock transaction, combining facial recognition…
2 years ago
Pan American Silver Reports Third Quarter 2023 Results
All amounts expressed in U.S. dollars unless otherwise indicated. Unaudited tabular amounts are in millions…
2 years ago
James Hardie Industries Announces Second Quarter Fiscal Year 2024 Results
Record Adjusted Net Income of US$178.9 Million Record First Half Operating Cash Flow of US$459.1…
2 years ago
Lumentum Announces Completion of Cloud Light Acquisition
SAN JOSE, Calif.--(BUSINESS WIRE)--Lumentum Holdings Inc. (NASDAQ: LITE) (“Lumentumâ€) today announced that it has completed…
2 years ago
AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer
SYDNEY--(BUSINESS WIRE)--AdvanCell, a radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for cancer patients,…
2 years ago
China’s Passenger Car Radar Industry Sees Explosive Growth, with Over 20 Million Installations in 2023 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Passenger Car Radar Industry, 2022-2023" report has been added to ResearchAndMarkets.com's offering. China's…
2 years ago
Wasabi Technologies Partners with Leading Security Providers to Deliver Next-Generation Cloud Storage to Australia and New Zealand Surveillance Industry
Fast, affordable cloud storage from Wasabi now available in Channel Ten and Visium Networks portfolios…
2 years ago
Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic…
2 years ago
Vicat: Nine-Month 2023 Sales
 L’ISLE D’ABEAU, France--(BUSINESS WIRE)--Regulatory News: Vicat (Paris:VCT): â–¼ Strong growth in third-quarter sales (up…
2 years ago